Insights Home Insights Featured Content Case Study- Technology Case Study: Wireless Technology Expert Needed for Smartphone Device Dispute In a dispute over patented IC packaging technology used in smartphones, the plaintiff sought WIT's help to provide a expert in wireless technology with experience in noise isolation, wafer-level packaging, and trial testimony. Blog A Crypto Expert Discusses Disruptive Innovation in Financial Technology To delve deeper into industry trends, we reconnected with Dr. Richard to discuss the latest innovations and advancements in financial technology and how they might impact the industry. Case Study- Life Sciences Case Study: Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs The defendant approached WIT to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study to learn how WIT was able to meet the expert need. Blog An Expert’s Look at the Cryptocurrency Market in 2024 The financial industry's struggles have intensified since the pandemic due to cryptocurrency volatility, resulting in ongoing litigation and anticipated future disputes. WIT's crypto expert provides insights into the evolving financial technology landscape, focusing on regulatory scrutiny and potential litigation risks in 2024. Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings. Insights & News All Industries Automotive Biotechnology Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications All Trends 2023 Banking Crisis 5G / 6G COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Lab-Grown Foods Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Article Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Report Video Search July 10, 2024 — Case Study- Life Sciences Case Study: Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs The defendant approached WIT to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study to learn how WIT was able to meet the expert need. June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings. June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings. October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets. February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP. July 14, 2021 — Blog FDA Approvals, Controversial Therapeutics, and the Experts Needed for Litigation Therapeutics are some of the most complicated, most regulated, and most litigated products existing in the market today. Any inconsistencies to the qualification and validation protocols of the product can cause undue harm, lasting damage, and unlimited claims of liability. June 16, 2021 — Blog Biologics vs. Biosimilars – Driving Innovation, BPCIA Litigation, and a Need for Experts With patents for several existing biological drugs set to expire in the coming decade, biosimilar companies and manufacturers have an opportunity to take advantage. Load More Loading...
Case Study- Technology Case Study: Wireless Technology Expert Needed for Smartphone Device Dispute In a dispute over patented IC packaging technology used in smartphones, the plaintiff sought WIT's help to provide a expert in wireless technology with experience in noise isolation, wafer-level packaging, and trial testimony.
Blog A Crypto Expert Discusses Disruptive Innovation in Financial Technology To delve deeper into industry trends, we reconnected with Dr. Richard to discuss the latest innovations and advancements in financial technology and how they might impact the industry.
Case Study- Life Sciences Case Study: Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs The defendant approached WIT to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study to learn how WIT was able to meet the expert need.
Blog An Expert’s Look at the Cryptocurrency Market in 2024 The financial industry's struggles have intensified since the pandemic due to cryptocurrency volatility, resulting in ongoing litigation and anticipated future disputes. WIT's crypto expert provides insights into the evolving financial technology landscape, focusing on regulatory scrutiny and potential litigation risks in 2024.
Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.
July 10, 2024 — Case Study- Life Sciences Case Study: Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs The defendant approached WIT to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study to learn how WIT was able to meet the expert need.
June 18, 2024 — Report A National Study of Community Attitudes Toward Pharmaceutical Companies WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.
June 12, 2024 — Report Hatch-Waxman Spotlight: Senior Judge Richard Andrews Our latest Hatch-Waxman report provides a comprehensive analysis of Senior Judge Richard Andrews' activity at the United States District Court for the District of Delaware since his appointment in November 2011. Learn more about our findings.
October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets.
February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP.
July 14, 2021 — Blog FDA Approvals, Controversial Therapeutics, and the Experts Needed for Litigation Therapeutics are some of the most complicated, most regulated, and most litigated products existing in the market today. Any inconsistencies to the qualification and validation protocols of the product can cause undue harm, lasting damage, and unlimited claims of liability.
June 16, 2021 — Blog Biologics vs. Biosimilars – Driving Innovation, BPCIA Litigation, and a Need for Experts With patents for several existing biological drugs set to expire in the coming decade, biosimilar companies and manufacturers have an opportunity to take advantage.